Imaging of central nAChReceptors with 2-[18F]F-A85380: optimized synthesis and in vitro evaluation in Alzheimer's disease

Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
Joern SchmaljohannUllrich Wüllner

Abstract

In vivo labeling of the nicotinic acetylcholine receptors (nAChR) could be a useful tool for early diagnosis of neurodegenerative disorders. 2-[18F]F-A85380 (2-[18F]Fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine), a ligand with high affinity to the beta2 subunit of the nAChRs, has been shown to label neurons in the nAChR-rich thalamus, cortex and striatum in baboons. We report an optimized synthesis resulting in an uncorrected yield of 58% in 45 min (precursor 2), enabling efficient production intended for clinical use. Incubation of normal rat brain sections with 2-[18F]F-A85380 with subsequent autoradiographic analyses showed the expected distribution in nAChR areas. In human brain sections of Alzheimer's disease (AD) a decrease of 2-[18F]F-A85380 uptake to 36% of the control group was measured in the thalamus and also in the occipital cortex. These findings suggest that 2-[18F]F-A85380 is a promising PET-ligand in the diagnosis of AD.

References

Nov 1, 1992·International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology·C HalldinH Nybäck
Apr 16, 1986·Brain Research·P J WhitehouseK J Kellar
Mar 1, 1997·Dementia and Geriatric Cognitive Disorders·A NordbergB Långström
Jan 15, 1998·Nuclear Medicine and Biology·P E MolinaJ S Fowler
Jan 22, 1998·Journal of Medicinal Chemistry·M W HolladayJ K Lynch
Nov 6, 1998·Nuclear Medicine and Biology·A G HortiR F Dannals

❮ Previous
Next ❯

Citations

Dec 25, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Kjell NågrenJuha O Rinne
Apr 7, 2006·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Jan BuceriusMichael J Reinhardt
Feb 24, 2007·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Bengt LångströmHåkan Hall
Mar 14, 2007·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Robert M Cohen
Feb 19, 2013·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·Steffen FischerPeter Brust
Dec 1, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·J T O'BrienE D Williams
Apr 24, 2007·Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine·Andreas SchildanOsama Sabri
Apr 12, 2017·International Journal of Molecular Sciences·Claire TronelNicolas Arlicot
Dec 12, 2013·Journal of Labelled Compounds & Radiopharmaceuticals·Jason P HollandNeil Vasdev
Aug 10, 2018·Multiple Sclerosis : Clinical and Laboratory Research·Heidi HögelLaura Airas
Feb 22, 2005·Nuclear Medicine Communications·Sally L Pimlott
Jan 28, 2021·Seminars in Nuclear Medicine·Aren van WaardeRudi A J O Dierckx
Jul 11, 2021·European Journal of Nuclear Medicine and Molecular Imaging·Nadja Van CampHervé Boutin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Alzheimer's Disease: Early Markers

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.